In an effort to boost the vaccination program, India has decided to phase out local trials for "well-established" foreign coronavirus vaccines. India had promised to accelerate imports last month, but a dispute over local tests and a dispute over indemnification stalled discussions with Pfizer.

India scrap local trials for "well-established" imported COVID-19 vaccine

US President Donald Trump has announced the nuances of the 'warp-speed' effort to create coronavirus vaccine by year's end, defying expert warnings that such a breakthrough could take longer than 18 months.

During remarks in the White House Rose Garden on Friday, he likened the vaccine project, dubbed "Operation Warp Speed", to the World War Two effort to produce the world's first nuclear weapons.

Also read:&nbsp;<a href="https://www.wionews.com/world/us-house-passes-3-trillion-coronavirus-aid-bill-fate-uncertain-in-senate-298971" hreflang="en">US House passes $3 trillion coronavirus aid bill, fate uncertain in Senate</a>

The project would begin with studies on 14 promising vaccine candidates for accelerated research and approval.

Trump called the operation, "a&nbsp;massive scientific, industrial and logistical endeavour unlike anything our country has seen since the Manhattan Project."

Moncef Slaoui, who previously led the vaccines division at pharmaceutical giant GlaxoSmithKline, will lead the mission, while Gen Gustave Perna, who oversees distribution for the US Army, is to serve as chief operating officer.

He insisted that US is reopening,&nbsp;''vaccine or no vaccine, we’re back.''

In testimony to Congress on Tuesday, Fauci, director of the National Institute of Allergy and Infectious Diseases, warned: “There’s no guarantee that the vaccine is actually going to be effective.”

And on Thursday Rick Bright, the ousted head of a government agency seeking a vaccine, told Congress: “Normally, it takes up to 10 years to make a vaccine. A lot of optimism is swirling around a 12-to-18-month time frame, if everything goes perfectly. We’ve never seen everything go perfectly.”

&nbsp;

&nbsp;

&nbsp;

&nbsp;

<ul>
</ul>

US President Donald Trump has announced the nuances of the 'warp-speed' effort to create coronavirus vaccine by year's end, defying expert warnings that such a breakthrough could take longer than 18 months.

US President Donald Trump has announced the nuances of the 'warp-speed' effort to create coronavirus vaccine by year's end, defying expert warnings that such a breakthrough could take longer than 18 months. During remarks in the White House Rose Garden on Friday, he likened the vaccine project, dubbed "Operation Warp Speed", to the World War Two effort to produce the world's first nuclear weapons. Also read: US House passes $3 trillion coronavirus aid bill, fate uncertain in Senate The project would begin with studies on 14 promising vaccine candidates for accelerated research and approval. Trump called the operation, "a massive scientific, industrial and logistical endeavour unlike anything our country has seen since the Manhattan Project." Moncef Slaoui, who previously led the vaccines division at pharmaceutical giant GlaxoSmithKline, will lead the mission, while Gen Gustave Perna, who oversees distribution for the US Army, is to serve as chief operating officer. He insisted that US is reopening, ''vaccine or no vaccine, we’re back.'' In testimony to Congress on Tuesday, Fauci, director of the National Institute of Allergy and Infectious Diseases, warned: “There’s no guarantee that the vaccine is actually going to be effective.” And on Thursday Rick Bright, the ousted head of a government agency seeking a vaccine, told Congress: “Normally, it takes up to 10 years to make a vaccine. A lot of optimism is swirling around a 12-to-18-month time frame, if everything goes perfectly. We’ve never seen everything go perfectly.”

Trump unveils operation 'warp speed' for rapid vaccine development

Gilead is a&nbsp;company that makes Remdesivir, another drug, that experts say holds promise against coronavirus.

In the US, Remdesivir is undergoing clinical trials. America's top health expert Dr. Anthony Fauci says it can block the virus.

That one statement made heads turn. Not just doctors, even investors began betting on Remdesivir.&nbsp;Needless to say, this was a shot in the arm for Gilead. Its shares gained by six per cent after the endorsement from Dr. Fauci.

<a href="https://www.wionews.com/india-news/53000-total-covid-19-cases-in-india-now-death-toll-jumps-to-1783-297123">Also read:&nbsp;53,000 total COVID-19 cases in India now; death toll jumps to 1783</a>

Five days ago, the federal drug administration in the United States has given its approval to Remdesivir. US&nbsp;President Donald Trump made the announcement himself, with Gilead CEO&nbsp;standing right next to him.

But, will Remdesivir be the cure that no one can afford? Gilead is under watch, not because it has one of the most promising coronavirus treatments.

US Lawmakers want to know how much Gilead will charge for Remdesivir&nbsp;because Gilead has a reputation for charging sky high prices.

In 2015, the company had charged 84 thousand dollars for a Hepatitis C drug. It didn't happen by accident, this was by design.

The Senate finance committee invested Gilead's pricing. This is a standing committee of lawmakers in the US&nbsp;Senate.

Gilead knew that affordable pricing would allow more patients to be treated. But, it still pursued profits. The company wanted to maximize its profits. What it didn't anticipate was the angry backlash; Gilead had to suffer through a spate of bad publicity.

Gilead is a company that makes Remdesivir, another drug, that experts say holds promise against coronavirus. In the US, Remdesivir is undergoing clinical trials.

Gilead is a company that makes Remdesivir, another drug, that experts say holds promise against coronavirus. In the US, Remdesivir is undergoing clinical trials. America's top health expert Dr. Anthony Fauci says it can block the virus. That one statement made heads turn. Not just doctors, even investors began betting on Remdesivir. Needless to say, this was a shot in the arm for Gilead. Its shares gained by six per cent after the endorsement from Dr. Fauci. Also read: 53,000 total COVID-19 cases in India now; death toll jumps to 1783 Five days ago, the federal drug administration in the United States has given its approval to Remdesivir. US President Donald Trump made the announcement himself, with Gilead CEO standing right next to him. But, will Remdesivir be the cure that no one can afford? Gilead is under watch, not because it has one of the most promising coronavirus treatments. US Lawmakers want to know how much Gilead will charge for Remdesivir because Gilead has a reputation for charging sky high prices. In 2015, the company had charged 84 thousand dollars for a Hepatitis C drug. It didn't happen by accident, this was by design. The Senate finance committee invested Gilead's pricing. This is a standing committee of lawmakers in the US Senate. Gilead knew that affordable pricing would allow more patients to be treated. But, it still pursued profits. The company wanted to maximize its profits. What it didn't anticipate was the angry backlash; Gilead had to suffer through a spate of bad publicity.

Gilead starts clinical trials of Remdesivir with US lawmakers curious about selling price

In the absence of a<a href="https://www.wionews.com/world/not-allergic-to-any-investigation-but-top-priority-to-fight-win-against-covid-19-china-297005"> COVID-19 </a>vaccine, antibody drugs are being touted as the next best thing.&nbsp;

<a href="https://www.wionews.com/world/most-americans-would-take-coronavirus-vaccine-if-deemed-safe-reuters-poll-296938">Also Read:&nbsp;Most Americans would take coronavirus vaccine if deemed safe</a>

Antibodies are created by our body's immune system. Scientists can harvest and then isolate them from a recovered patient's body. Israel and the Netherlands have had success in doing it.

Once antibodies are isolated, their genetic formula can be studied and replicated on a mass scale. The human body creates hundreds of antibodies - each specific to different pathogens.

It defeats the foreign cells by latching on to their surface and disables it. The physical shape and size of antibodies are quite crucial if the proportions are off, the antibodies will not be effective.

However, they are different from vaccines, antibody drugs are a cure, they cannot offer immunity to a population that has not been infected.

Vaccines on the other hand are preventive in nature. Antibody drugs bind themselves to infected cells upon injection.&nbsp;

While vaccines involve infecting the population with weak or inactivated virus samples, antibody drugs stimulate the immune system to attack the infected cells.

In the case of vaccines, the body creates antibodies by itself to fight the inactivated virus samples. They essentially work as a dress rehearsal, so that the body is ready for a full-blown infection.

Vaccines also take a longer time to develop, by conservative estimates it takes at least one year for a fool-proof vaccine to be deploid. However, antibody drugs can be developed in a matter of months as proven by institutes in Israel and the Netherlands.

And finally, vaccines generally have universal deployability. Most people can get vaccinated unless they are allergic to the formula but antibody treatments are advised only for infected patients and high-risk population groups.

In the absence of a COVID-19 vaccine, antibody drugs are being touted as the next best thing. Also Read: Most Americans would take coronavirus vaccine if deemed safe Antibodies are created by our body's immune system.

In the absence of a COVID-19 vaccine, antibody drugs are being touted as the next best thing. Also Read: Most Americans would take coronavirus vaccine if deemed safe Antibodies are created by our body's immune system. Scientists can harvest and then isolate them from a recovered patient's body. Israel and the Netherlands have had success in doing it. Once antibodies are isolated, their genetic formula can be studied and replicated on a mass scale. The human body creates hundreds of antibodies - each specific to different pathogens. It defeats the foreign cells by latching on to their surface and disables it. The physical shape and size of antibodies are quite crucial if the proportions are off, the antibodies will not be effective. However, they are different from vaccines, antibody drugs are a cure, they cannot offer immunity to a population that has not been infected. Vaccines on the other hand are preventive in nature. Antibody drugs bind themselves to infected cells upon injection. While vaccines involve infecting the population with weak or inactivated virus samples, antibody drugs stimulate the immune system to attack the infected cells. In the case of vaccines, the body creates antibodies by itself to fight the inactivated virus samples. They essentially work as a dress rehearsal, so that the body is ready for a full-blown infection. Vaccines also take a longer time to develop, by conservative estimates it takes at least one year for a fool-proof vaccine to be deploid. However, antibody drugs can be developed in a matter of months as proven by institutes in Israel and the Netherlands. And finally, vaccines generally have universal deployability. Most people can get vaccinated unless they are allergic to the formula but antibody treatments are advised only for infected patients and high-risk population groups.

How antibody drugs are different from vaccines

Pharmaceutical companies have been racing against time to develop vaccines as the death toll and infections around the world continue to spike.

US begins first human trial of coronavirus vaccine